Expression of bcl-2 in invasive and in situ carcinoma of the uterine cervix.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  American Journal of Obstetrics and Gynecology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0002-9378(98)70636-2PMID 9465813
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic value of bcl-2 expression in patients with operable carcinoma of the uterine cervix.

  1997cited by this paper
• BCL‐2 IMMUNOREACTIVITY INCREASES WITH SEVERITY OF CIN: A STUDY OF NORMAL CERVICAL EPITHELIA, CIN, AND CERVICAL CARCINOMA

  1996cited by this paper
• bcl-2, p53 and proliferating cell nuclear antigen expression is related to the degree of differentiation in thyroid carcinomas.

  1996cited by this paper
• Persistent expression of bcl-2 onco-protein in endometrial carcinoma correlates with hormone receptor positivity

  1996cited by this paper
• Cervical and vulva cancer: changes in FIGO definitions of staging

  1996cited by this paper
• Apoptosis and immunohistochemical bcl‐2 expression in colorectal adenomas and carcinomas: Aspects of carcinogenesis and prognostic significance

  1996cited by this paper
• Prognostic value of bcl-2 expression in invasive breast cancer.

  1995cited by this paper
• Bcl‐2 protooncogene expression in cervical carcinoma cell lines containing inactive p53

  1995cited by this paper
• Expression of bcl‐2 gene product in neuroblastoma

  1994cited by this paper
• Apoptosis. Its significance in cancer and cancer Therapy

  1994cited by this paper
• Apoptosis as predictor of response to radiotherapy in cervical carcinoma.

  1994cited by this paper
• BCL‐2 expression in adult and embryonic non‐haematopoietic tissues

  1993cited by this paper
• Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes.

  1993cited by this paper
• Expression of bcl-2 in fetal tissues suggests a role in morphogenesis.

  1993cited by this paper
• bcl-2 protein in non-small-cell lung carcinoma.

  1993cited by this paper
• BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.

  1991cited by this paper
• Membrane topology of the Bcl-2 proto-oncogenic protein demonstrated in vitro.

  1990cited by this paper
• Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma.

  1986cited by this paper
• Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation.

  1986cited by this paper
• Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18.

  1985cited by this paper
• Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation.

  1984cited by this paper
• Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma.

  1982cited by this paper
• Regression Models and Life-Tables

  1972cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• HPV infection and its correlation with p53 and Bcl-2 among pregnant mothers and their infants

  2024cites this paper
• Polarizable Simulations of the bcl-2 DNA G-Quadruplex and FMRP RNA G- Quadruplex:Duplex Junction Binding Protein

  2021cites this paper
• Cervical Stratified Mucin-Producing Intraepithelial Lesion: A Systematic Review of Diagnosis and Management

  2020cites this paper
• Targeting the B-cell lymphoma 2 anti-apoptotic proteins for cervical cancer treatment.

  2020cites this paper
• Ion Binding Properties and Dynamics of the bcl-2 G-Quadruplex Using a Polarizable Force Field

  2020cites this paper
• Neoplasms of the Cervix

  2019cites this paper
• Immunohistochemical Expression of p53 and Bcl-2 in Algerian Cervical Carcinoma

  2018cites this paper
• Targeting Promoter Quadruplex Nucleic Acids for Cancer Therapy

  2017cites this paper
• IMMUNOHISTOCHEMICAL EXPRESSION OF P53, BCL2 AND CD34 IN CERVICAL INTRAEPITHELIAL NEOPLASIAS AND CARCINOMAS

  2016cites this paper
• Interaction of Individual Structural Domains of hnRNP LL with the BCL2 Promoter i-Motif DNA.

  2016cites this paper
• Bcl-2 confers survival in cisplatin treated cervical cancer cells: circumventing cisplatin dose-dependent toxicity and resistance

  2015cites this paper
• p53 and bcl2 expression in malignant and premalignant lesions of uterine cervix and their correlation with human papilloma virus 16 and 18

  2014influential citation
• The Major G-Quadruplex Formed in the Human BCL-2 Proximal Promoter Adopts a Parallel Structure with a 13-nt Loop in K+ Solution

  2014cites this paper
• Emulsified BMVC derivative induced filtration for G-quadruplex DNA structural separation

  2011cites this paper
• Investigation of the formation and recognition of a dimeric G-quadruplex in the promoter of Bcl-2 proto-oncogene by electrospray ionization mass spectrometry.

  2010cites this paper
• Structural insights into G-quadruplexes: towards new anticancer drugs.

  2010cites this paper
• The i-motif in the bcl-2 P1 promoter forms an unexpectedly stable structure with a unique 8:5:7 loop folding pattern.

  2009cites this paper
• Correlation among six biologic factors (p53, p21(WAF1), MIB-1, EGFR, HER2, and Bcl-2) and clinical outcomes after curative chemoradiation therapy in squamous cell cervical cancer.

  2009cites this paper
• Stabilization of G-quadruplex in the BCL2 promoter region in double-stranded DNA by invading short PNAs

  2009cites this paper
• What Do the Clinical Data Tell Us About the Role of Apoptosis in Sensitivity to Cancer Therapy

  2008cites this paper
• Expression of Ki-67 and squamous intraepithelial lesions are related with HPV in endocervical adenocarcinoma

  2008cites this paper
• AVALIAÇÃO DA ATIVIDADE APOPTÓTICA DE SUBSTÂNCIA PURA ISOLADA DE Cryptocarya mandioccana EM CÉLULAS DE CARCINOMA CERVICAL IMORTALIZADAS PELO PAPILOMAVÍRUS HUMANO (HPV).

  2007cites this paper
• Association between Bcl-2 expression and tumor recurrence in cervical cancer: a matched case-control study.

  2006cites this paper
• Significance of Bcl-2 and Bax proteins in cervical carcinogenesis: an immunohistochemical study in squamous cell carcinoma and squamous intraepithelial lesions.

  2006cites this paper
• NMR solution structure of the major G-quadruplex structure formed in the human BCL2 promoter region

  2006cites this paper
• An intramolecular G-quadruplex structure with mixed parallel/antiparallel G-strands formed in the human BCL-2 promoter region in solution.

  2006cites this paper
• Deconvoluting the structural and drug-recognition complexity of the G-quadruplex-forming region upstream of the bcl-2 P1 promoter.

  2006cites this paper
• Expression of apoptosis-related proteins in advanced uterine cervical cancer after balloon-occluded arterial infusion chemotherapy as an indicator of the efficiency of this therapy.

  2005cites this paper
• Recurrence and survival predictive value of phenotypic expression of Bcl-2 varies with tumor stage of colorectal adenocarcinoma

  2005cites this paper
• Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix.

  2005cites this paper
• Molecular mechanism of chemoresistance to cisplatin in ovarian cancer cell lines.

  2004cites this paper
• Detection of bcl-2 and bax expression and bcl-2/JH fusion gene in intrahepatic cholangiocarcinoma.

  2004cites this paper
• Estrogen receptor, progesterone receptor, and bcl-2 are markers with prognostic significance in CIN III

  2003cites this paper
• Changes in the topological expression of markers of differentiation and apoptosis in defined stages of human cervical dysplasia and carcinoma.

  2003cites this paper
• Chemosensitivity and p53-Bax pathway-mediated apoptosis in patients with uterine cervical cancer.

  2003cites this paper
• Paradoxical role of apoptosis in tumor progression

  2003cites this paper
• Bcl-2 expression in preinvasive and invasive cervical lesions.

  2002cites this paper
• SCC antigen in the serum as an independent prognostic factor in operable squamous cell carcinoma of the cervix.

  2002cites this paper
• Hepatocellular Carcinoma and Markers of Apoptosis (bcl-2, bax, bcl-x): Prognostic Significance

  2002cites this paper
• The Molecular Biology of Cervical Cancer

  2001cites this paper
• Bcl - 2 Expression in Carcinoma of the Uterine Cervix and its Relationship with Prognostic Variables

  2001cites this paper
• Biologic factors and response to radiotherapy in carcinoma of the cervix

  2001cites this paper
• Dysplasien und Neoplasien des Plattenepithels der Zervix

  2001cites this paper
• Bcl – 2 Expression in Carcinoma of the Uterine Cervix and its Relationship with Prognostic Variables

  2001cites this paper
• The importance of biological factors (bcl-2, bax, p53, PCNA, MI, HPV and angiogenesis) in invasive cervical cancer.

  2001cites this paper
• Prognostic value of bcl-2, p53 and Ki-67 in invasive squamous carcinoma of the uterine cervix.

  2000cites this paper
• Detection of Apoptosis and Expression of Apoptosis‐associated Proteins as Early Predictors of Prognosis after Irradiation Therapy in Stage IIIb Uterine Cervical Cancer

  2000cites this paper
• Bcl-2, bax, bcl-x(L) and bcl-x(S) expression in neoplastic and normal cervical tissue.

  2000cites this paper
• [Diagnosis and therapy of cervical squamous epithelial carcinomas].

  1999cites this paper
• Diagnostik und Therapie zervikaler Plattenepithelkarzinome

  1999cites this paper
• Prognostic significance of the bcl-2 apoptotic family of proteins in primary and recurrent cervical cancer.

  1998cites this paper